<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2019-1-16(391)-37-43</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-1291</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Свободный гемоглобин и сепсис</article-title><trans-title-group xml:lang="en"><trans-title>Free hemoglobin and sepsis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлов</surname><given-names>Ю. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlov</surname><given-names>Yu. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра анестезиологии и реаниматологии</p><p>г. Омск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Говорова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Govorova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра анестезиологии и реаниматологии</p><p>г. Омск</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Храмых</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Khramykh</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра оперативной хирургии и топографической анатомии</p><p>г. Омск</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глущенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Glushchenko</surname><given-names>A. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ночная</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nochnaya</surname><given-names>Yu. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра анестезиологии и реаниматологии</p><p>г. Омск</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Омский государственный медицинский университет» Минздрава России; БУЗОО «Городская клиническая больница скорой медицинской помощи № 1», г. Омск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University; Сity Clinical Emergency Hospital N 1, Omsk</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Омский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>БУЗОО «Городская клиническая больница скорой медицинской помощи № 1», г. Омск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Сity Clinical Emergency Hospital N 1, Omsk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>11</month><year>2019</year></pub-date><volume>1</volume><issue>16</issue><issue-title>Неотложная медицина и кардиология</issue-title><fpage>37</fpage><lpage>43</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Орлов Ю.П., Говорова Н.В., Храмых Т.П., Глущенко А.В., Ночная Ю.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Орлов Ю.П., Говорова Н.В., Храмых Т.П., Глущенко А.В., Ночная Ю.А.</copyright-holder><copyright-holder xml:lang="en">Orlov Y.P., Govorova N.V., Khramykh T.P., Glushchenko A.V., Nochnaya Y.А.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/1291">https://www.med-alphabet.com/jour/article/view/1291</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: определение возможности использования концентрации свободного гемоглобина как раннего прогностического маркера и предиктора летальности при сепсисе.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследовании у 60 пациентов в возрасте 47,6 ± 7,2 года с сепсисом (30,4 ± 2,1 балла по шкале Манхейма для оценки тяжести перитонита) методами современной статистики (ROC-анализ) была проверена гипотеза, действительно ли уровень свободного гемоглобина, определяемый в первые сутки от момента госпитализации, может быть использован в качестве биомаркера для диагностики и прогноза тяжелого сепсиса. Информативность критерия сравнивали с информативностью прокальцитонинового теста.</p></sec><sec><title>Результаты</title><p>Результаты. Настоящее исследование показало, что концентрация свободного гемоглобина выше средней величины, измеренной в первый день течения тяжелого сепсиса, прямо связана с увеличением 30-дневной смертности, а уровень свободного гемоглобина в 1-е сутки заболевания обладает высокой чувствительностью, специфичностью и с точностью до 96,7 % может определить исход сепсиса.</p></sec><sec><title>Заключение</title><p>Заключение. Концентрация свободного гемоглобина выше средней величины, выявленная в первый день течения тяжелого сепсиса, прямо связана с увеличением 30-дневной смертности, а исследованный уровень свободного гемоглобина в 1-е сутки течения заболевания обладает высокой долей чувствительности и специфичности. Уровень свободного гемоглобина является чувствительным предиктором исхода сепсиса в первые сутки после начала терапии, но полученные результаты никак не исключают необходимости использования прокальцитонинового теста у септических пациентов, а напротив, диктуют целесообразность сочетания двух указанных критериев для оценки исхода тяжелого септического процесса, что требует продолжения исследований.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose of Research</title><p>Purpose of Research: to determine whether we can use free hemoglobin concentration as early prognostic marker and a predictor of mortality in sepsis.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. In a retrospective study in 60 patients aged 47.6 ± 7.2 years with sepsis (30.4 ± 2.1 points on the Mannheim’s scale for evaluation of the severity of peritonitis) modern methods of statistics (ROC-analysis) hypothesis was tested, whether level of free hemoglobin in the first 24 hours from the moment of admission can be used as a biomarker for diagnosis and prognosis for severe sepsis. Informative criterion was compared with the information of the procalcitonin test.</p></sec><sec><title>Results</title><p>Results. The present study had shown that the above average free hemoglobin concentration, measured on the first day of the heavy flow of sepsis, is directly connected with increased 30-days mortality, and the level of free hemoglobin in a first day of the disease has high sensitivity, specificity, and can determine the outcome of sepsis with accuracy up to 96.7 %.</p></sec><sec><title>Conclusion</title><p>Conclusion. Free hemoglobin concentration above medium size identified on the first day of the currents of severe sepsis, is directly related to increased 30-day mortality, and researched level of free hemoglobin in day 1 of the disease has a high proportion of sensitivity and specificity. Level of free hemoglobin is predictor outcome of sepsis in the first 24 hours after the start of therapy, but the results did not rule out the need to use the necessary test from septic patients, but rather the feasibility of combining the two dictates the criteria to assess the outcome of severe septic process that requires further research.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>свободный гемоглобин</kwd><kwd>сепсис</kwd><kwd>ROC-анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>free hemoglobin</kwd><kwd>procalcitonin</kwd><kwd>sepsis</kwd><kwd>ROC-analysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Weis S, Carlos AR, Moita MR, Singh S, Blankenhaus B, Cardoso S. et al. Metabolic Adaptation Establishes Disease Tolerance to Sepsis. Cell. 2017 Jun 15; 169 (7): 1263–1275.e14. doi: 10.1016/j.cell.2017.05.031.</mixed-citation><mixed-citation xml:lang="en">Weis S, Carlos AR, Moita MR, Singh S, Blankenhaus B, Cardoso S. et al. Metabolic Adaptation Establishes Disease Tolerance to Sepsis. Cell. 2017 Jun 15; 169 (7): 1263–1275.e14. doi: 10.1016/j.cell.2017.05.031.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE. et al. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001 Aug 1; 164 (3): 396–402.</mixed-citation><mixed-citation xml:lang="en">Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE. et al. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001 Aug 1; 164 (3): 396–402.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med. 2000 Aug; 28 (8): 2793–8.</mixed-citation><mixed-citation xml:lang="en">Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med. 2000 Aug; 28 (8): 2793–8.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yu X, Ma X, Ai Y. Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jun; 27 (6): 477–83. doi: 10.3760/cma.j.issn.2095–4352.2015.06.012.</mixed-citation><mixed-citation xml:lang="en">Yu X, Ma X, Ai Y. Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jun; 27 (6): 477–83. doi: 10.3760/cma.j.issn.2095–4352.2015.06.012.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jordi Rello J, Francisco Valenzuela-Sánchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: A Review of Advances in Management. Adv Ther. 2017; 34 (11): 2393–2411. doi: 10.1007/s12325–017–0622–8.</mixed-citation><mixed-citation xml:lang="en">Jordi Rello J, Francisco Valenzuela-Sánchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: A Review of Advances in Management. Adv Ther. 2017; 34 (11): 2393–2411. doi: 10.1007/s12325–017–0622–8.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мчедлишвили Г. И. Гемореология в системе микроциркуляции: ее специфика и практическое значение. Тромбоз, гемостаз и реология. 2002; 4 (12); 18–24.</mixed-citation><mixed-citation xml:lang="en">Mchedlishvili GI. Gemoreologiya v sisteme mikrotsirkulyatsii: eye spetsifika i prakticheskoye znacheniye. Tromboz. gemostaz i reologiya.2002; 4 (12); 18–24. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Сторожук П. Г. Ферменты прямой и косвенной антирадикальной защиты эритроцитов и их роль в инициации процессов оксигенации гемоглобина, антибактериальной защите и делении клеток. Вестн. интенсив. терапии 2000; 3: 8–13.</mixed-citation><mixed-citation xml:lang="en">Storozhuk PG. Fermenty pryamoy i kosvennoy antiradikalnoy zashchity eritrotsitov i ikh rol v initsiatsii protsessov oksigenatsii gemoglobina. antibakterialnoy zashchite i delenii kletok. Vestn. intensive therapy 2000; 3: 8–13. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Huffman DL, Bischof LJ, Griffitts JS, Aroian RV. Pore worms: using Caenorhabditis elegans to study how bacterial toxins interact with their target host. Int J Med Microbiol. 2004; 293: 599–607. doi: 10.1078/1438–4221–00303.</mixed-citation><mixed-citation xml:lang="en">Huffman DL, Bischof LJ, Griffitts JS, Aroian RV. Pore worms: using Caenorhabditis elegans to study how bacterial toxins interact with their target host. Int J Med Microbiol. 2004; 293: 599–607. doi: 10.1078/1438–4221–00303.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Aroian R, van der Goot FG. Pore-forming toxins and cellular nonimmune defenses (CNIDs) Curr Opin Microbiol. 2007; 10: 57–61. doi: 10.1016/j.mib.2006.12.008.</mixed-citation><mixed-citation xml:lang="en">Aroian R, van der Goot FG. Pore-forming toxins and cellular nonimmune defenses (CNIDs) Curr Opin Microbiol. 2007; 10: 57–61. doi: 10.1016/j.mib.2006.12.008.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez MR, Bischofberger M, Pernot L, van der Goot FG, Freche B. Bacterial pore-forming toxins: the (w) hole story? Cell Mol Life Sci. 2008; 65: 493–507. doi: 10.1007/s00018–007–7434-y.</mixed-citation><mixed-citation xml:lang="en">Gonzalez MR, Bischofberger M, Pernot L, van der Goot FG, Freche B. Bacterial pore-forming toxins: the (w) hole story? Cell Mol Life Sci. 2008; 65: 493–507. doi: 10.1007/s00018–007–7434-y.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bull BS, Kuhn IN. The production of schistocytes by fibrin strands (a scanning electron microscope study) Blood. 1970; 35: 104–111.</mixed-citation><mixed-citation xml:lang="en">Bull BS, Kuhn IN. The production of schistocytes by fibrin strands (a scanning electron microscope study) Blood. 1970; 35: 104–111.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Heyes H, Köhle W, Slijepcevic B. The appearance of schistocytes in the peripheral blood in correlation to the degree of disseminated intravascular coagulation. An experimental study in rats. Haemostasis. 1976; 5: 66–73.</mixed-citation><mixed-citation xml:lang="en">Heyes H, Köhle W, Slijepcevic B. The appearance of schistocytes in the peripheral blood in correlation to the degree of disseminated intravascular coagulation. An experimental study in rats. Haemostasis. 1976; 5: 66–73.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med. 2011; 17: 317–329.</mixed-citation><mixed-citation xml:lang="en">Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med. 2011; 17: 317–329.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pöschl JM, Leray C, Ruef P, Cazenave JP, Linderkamp O. Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med. 2003; 31: 924–928. doi: 10.1097/01.CCM.0000055366.24147.80.</mixed-citation><mixed-citation xml:lang="en">Pöschl JM, Leray C, Ruef P, Cazenave JP, Linderkamp O. Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med. 2003; 31: 924–928. doi: 10.1097/01.CCM.0000055366.24147.80.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lang F, Gulbins E, Lang PA, Zappulla D, Föller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem. 2010; 26: 21–28. doi: 10.1159/000315102.</mixed-citation><mixed-citation xml:lang="en">Lang F, Gulbins E, Lang PA, Zappulla D, Föller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem. 2010; 26: 21–28. doi: 10.1159/000315102.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lang F, Qadri SM. Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes. Blood Purif 2012; 33: 125–130. doi: 10.1159/000334163.</mixed-citation><mixed-citation xml:lang="en">Lang F, Qadri SM. Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes. Blood Purif 2012; 33: 125–130. doi: 10.1159/000334163.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood. 2010; 115:4284– 4292. doi: 10.1182/blood-2009–10–245001.</mixed-citation><mixed-citation xml:lang="en">Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood. 2010; 115:4284– 4292. doi: 10.1182/blood-2009–10–245001.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dutra FF, Bozza MT. Heme on innate immunity and inflammation. Front Pharmacol. 2014 May 27; 5:115. doi: 10.3389/fphar.2014.00115. eCollection 2014.</mixed-citation><mixed-citation xml:lang="en">Dutra FF, Bozza MT. Heme on innate immunity and inflammation. Front Pharmacol. 2014 May 27; 5:115. doi: 10.3389/fphar.2014.00115. eCollection 2014.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vinchi F, Tolosano E. Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis. Oxid Med Cell Longev. 2013; 2013: 396527. doi: 10.1155/2013/396527. Epub 2013 May 27.</mixed-citation><mixed-citation xml:lang="en">Vinchi F, Tolosano E. Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis. Oxid Med Cell Longev. 2013; 2013: 396527. doi: 10.1155/2013/396527. Epub 2013 May 27.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Linder MM, Wacha H, Feldmann U, Wesch G, Streifensand RA, Gundlach E. The Mannheim peritonitis index. An instrument for the intraoperative prognosis of peritonitis. Chirurg. 1987 Feb; 58 (2): 84–92.</mixed-citation><mixed-citation xml:lang="en">Linder MM, Wacha H, Feldmann U, Wesch G, Streifensand RA, Gundlach E. The Mannheim peritonitis index. An instrument for the intraoperative prognosis of peritonitis. Chirurg. 1987 Feb; 58 (2): 84–92.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23; 315 (8): 801–10. doi: 10.1001/jama.2016.0287.</mixed-citation><mixed-citation xml:lang="en">Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23; 315 (8): 801–10. doi: 10.1001/jama.2016.0287.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Vincent JL, Ince C, Bakker J. Clinical review: Circulatory shock — an update: a tribute to Professor Max Harry Weil. Crit Care. 2012 Nov 20; 16 (6): 239. doi: 10.1186/cc11510.</mixed-citation><mixed-citation xml:lang="en">Vincent JL, Ince C, Bakker J. Clinical review: Circulatory shock — an update: a tribute to Professor Max Harry Weil. Crit Care. 2012 Nov 20; 16 (6): 239. doi: 10.1186/cc11510.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Савельев О. Н., Сухоруков В. П., Киселева А. В. Определение свободного гемоглобина плазмы крови гемиглобинцианидным методом. Лаб. дело. 1990; 10: 45–47.</mixed-citation><mixed-citation xml:lang="en">Savelyev ON, Sukhorukov VP, Kiseleva AV. Opredeleniye svobodnogo gemoglobina plazmy krovi gemiglobintsianidnym metodom. Lab. delo. 1990; 10: 45–47. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Мeisner M. PCT — procalcitonin. A new and innovative parameter in diagnosis of infections. B. R. A. H. M. S. Diagnostica. Berlin. 1996.</mixed-citation><mixed-citation xml:lang="en">Мeisner M. PCT — procalcitonin. A new and innovative parameter in diagnosis of infections. B. R. A. H. M. S. Diagnostica. Berlin. 1996.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Belcher JD, Mahaseth H, Welch TE, et al. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. American Journal of Physiology. 2005; 288 (6): 2715–2725.</mixed-citation><mixed-citation xml:lang="en">Belcher JD, Mahaseth H, Welch TE, et al. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. American Journal of Physiology. 2005; 288 (6): 2715–2725.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. Journal of Clinical Investigation. 2006; 116 (3): 808–816.</mixed-citation><mixed-citation xml:lang="en">Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. Journal of Clinical Investigation. 2006; 116 (3): 808–816.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002; 100 (3): 879–887.</mixed-citation><mixed-citation xml:lang="en">Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002; 100 (3): 879–887.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicology Letters. 2005; 157 (3): 175–188.</mixed-citation><mixed-citation xml:lang="en">Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicology Letters. 2005; 157 (3): 175–188.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberg ED. Iron and infection. Microbiol Rev. 1978 Mar; 42(1): 45–66.</mixed-citation><mixed-citation xml:lang="en">Weinberg ED. Iron and infection. Microbiol Rev. 1978 Mar; 42(1): 45–66.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cassat JE, Skaar EP. Iron in Infection and Immunity. Cell Host Microbe. 2013 May 15; 13(5): 509–519. doi: 10.1016/j.chom.2013.04.010.</mixed-citation><mixed-citation xml:lang="en">Cassat JE, Skaar EP. Iron in Infection and Immunity. Cell Host Microbe. 2013 May 15; 13(5): 509–519. doi: 10.1016/j.chom.2013.04.010.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Brauckmann S, Effenberger-Neidnicht K, de Groot H, Nagel M, Mayer Ch, Peters J, Hartmann M. Lipopolysaccharide-induced hemolysis: Evidence for direct membrane interactions. Sci Rep. 2016; 6: 35508. doi: 10.1038/srep35508.</mixed-citation><mixed-citation xml:lang="en">Brauckmann S, Effenberger-Neidnicht K, de Groot H, Nagel M, Mayer Ch, Peters J, Hartmann M. Lipopolysaccharide-induced hemolysis: Evidence for direct membrane interactions. Sci Rep. 2016; 6: 35508. doi: 10.1038/srep35508.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bloom O, Wang H, Ivanova S, Vishnubhakat JM, Ombrellino M, Tracey KJ. Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock. Shock. 1998;10: 395–400. doi: 10.1097/00024382–199812000–00003.</mixed-citation><mixed-citation xml:lang="en">Bloom O, Wang H, Ivanova S, Vishnubhakat JM, Ombrellino M, Tracey KJ. Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock. Shock. 1998;10: 395–400. doi: 10.1097/00024382–199812000–00003.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Lin T, Kwak YH, Sammy F, He P, Thundivalappil S, Sun G, et al. Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis. 2010; 202: 624–632. doi: 10.1086/654929.</mixed-citation><mixed-citation xml:lang="en">Lin T, Kwak YH, Sammy F, He P, Thundivalappil S, Sun G, et al. Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis. 2010; 202: 624–632. doi: 10.1086/654929.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graça-Souza AV, Bozza MT. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem. 2007; 282: 20221–20229. doi: 10.1074/jbc.M610737200.</mixed-citation><mixed-citation xml:lang="en">Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graça-Souza AV, Bozza MT. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem. 2007; 282: 20221–20229. doi: 10.1074/jbc.M610737200.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassú AM, et al. A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med. 2010; 2: 51–71. doi: 10.1126/scitranslmed.3001118.</mixed-citation><mixed-citation xml:lang="en">Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassú AM, et al. A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med. 2010; 2: 51–71. doi: 10.1126/scitranslmed.3001118.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares MP. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem. 2009; 284: 29582–29595. doi: 10.1074/jbc.M109.045344.</mixed-citation><mixed-citation xml:lang="en">Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares MP. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem. 2009; 284: 29582–29595. doi: 10.1074/jbc.M109.045344.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010; 50: 323–354. doi: 10.1146/annurev.pharmtox.010909.105600.</mixed-citation><mixed-citation xml:lang="en">Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010; 50: 323–354. doi: 10.1146/annurev.pharmtox.010909.105600.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Орлов Ю. П., Лукач В. Н., Долгих В. Т., Соболева Е. Л., Иванов А. В., Любавина А. Э. Критические состояния как логическая и закономерная цепь событий в нарушении метаболизма железа (обобщение экспериментальных исследований). Биомедицинская химия 2013; 59 (6): 700–709.</mixed-citation><mixed-citation xml:lang="en">Orlov Y. P., Lukach V. N., Dolgikh V. T., Soboleva, E.l. Ivanov A. V., Lyubavina A. E. et al. Kriticheskiye sostoyaniya kak logicheskaya i zakonomernaya tsep sobytiy v narushenii metabolizma zheleza (obobshcheniye eksperimentalnykh issledovaniy). Biomeditsinskaya khimiya 2013; 59 (6): 700–709. (In Russ).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
